| Pharmaceutical active ingredients: |
| Ondansetron Hydrochloride |
| Available forms, composition and doses of Zofran: |
| Injectable; Injection; Ondansetron Hydrochloride 2 mg / mlSolution; Oral; Ondansetron Hydrochloride 4 mg / 5 mlSuppositories; Rectal; Ondansetron Hydrochloride 16 mgTablets, Film-Coated; Oral; Ondansetron Hydrochloride 4 mgTablets, Film-Coated; Oral; Ondansetron Hydrochloride 8 mgTablets, Orally Disintegrating; Oral; Ondansetron Hydrochloride 4 mgTablets, Orally Disintegrating; Oral; Ondansetron Hydrochloride 8 mgTablets; Oral; Ondansetron Hydrochloride 24 mgTablets; Oral; Ondansetron Hydrochloride 4 mgTablets; Oral; Ondansetron Hydrochloride 8 mgTablets; Sublingual; Ondansetron Hydrochloride 4 mgTablets; Sublingual; Ondansetron Hydrochloride 8 mg |
| Zofran medical category: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA01 - Ondansetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKlineCatalent Pharma SolutionsFirma Chun CheongZuellig Pharma |
| Related documents and information about Zofran: |
| Zofran injection prescribing information (PDF)Zofran tablets prescribing information (PDF) |